News
Category:
 
logo_Merck[1]
CCPAPP and Merck would like to inform our members of the FDA's recent approval of an expanded indication for GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, Recombinant) for the Prevention of HPV-Related Oropharyngeal and other head and neck cancers.  read more
 
pfizer
CCPAPP and Pfizer recognize the challenges of providing preventative care for adolescents in the current environment. As your practice determines next steps to support adolescent preventative care, including immunization against vaccine-preventable diseases, Pfizer is committed to partnering with CCPAPP members to help prevent two key types of missed opportunities.  read more
 
logo_Merck[1]
CCPAPP and Merck would like to provide our members with some helpful information and reminders to ensure that Merck's vaccines are reaching providers and patients without disruption and as easily and efficiently as possible during this unprecedented COVID-19 pandemic.  read more
 
 
Results: 64 Article(s) Found.